VTv Net Debt from 2010 to 2024

VTVT Stock

USD 15.51 0.09 0.58%

VTv Therapeutics Net Debt yearly trend continues to be comparatively stable with very little volatility. Net Debt is likely to outpace its year average in 2024. Net Debt is the total debt of vTv Therapeutics minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2014-03-31

Previous Quarter

-45.3 M

Current Value

-41.4 M

Quarterly Volatility

32.1 M

Yuan Drop

Covid

Check VTv Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VTv Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 85.5 K, Interest Expense of 12.3 K or Selling General Administrative of 11.5 M, as well as many indicators such as Price To Sales Ratio of 27.56, Dividend Yield of 0.0 or Days Sales Outstanding of 2 K. VTv financial statements analysis is a perfect complement when working with VTv Therapeutics Valuation or Volatility modules.

Check out the analysis of VTv Therapeutics Correlation against competitors.

For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.

Latest VTv Therapeutics' Net Debt Growth Pattern

Below is the plot of the Net Debt of vTv Therapeutics over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. VTv Therapeutics' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in VTv Therapeutics' overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

VTv Net Debt Regression Statistics

	Arithmetic Mean	14,382,990
	Coefficient Of Variation	348.55
	Mean Deviation	38,826,407
	Median	5,336,000
	Standard Deviation	50,131,605
	Sample Variance	2513.2T
	Range	170.1M
	R-Value	(0.61)
	Mean Square Error	1711.3T
	R-Squared	0.37
	Significance	0.02
	Slope	(6,797,436)
	Total Sum of Squares	35184.5T

VTv Net Debt History

	2024	-8.5 M
	2023	-8.9 M
	2022	-11.4 M
	2021	-12.5 M
	2020	-4.8 M
	2019	5.3 M
	2018	14 M

Other Fundumenentals of vTv Therapeutics

Net Debt To E B I T D A

VTv Therapeutics Net Debt component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Property Plant Equipment	Net Tangible Assets	Long Term Investments	Short Long Term Debt	Capital Surpluse	Common Stock	Long Term Debt Total	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.23	-0.02	-0.67	0.46	0.35	-0.18	0.31	-0.33	-0.08	0.97	-0.23	-0.27	0.23	-0.17	0.63	-0.21	0.06	0.29	-0.27	0.08	0.13
Total Stockholder Equity	0.23		-0.18	-0.71	0.77	0.1	-0.42	0.26	0.14	-0.99	0.37	-0.61	-0.84	0.94	-0.56	0.32	0.68	0.3	-0.59	0.74	0.4	0.17
Current Deferred Revenue	-0.02	-0.18		0.01	-0.21	0.61	0.48	0.33	0.15	0.18	-0.04	-0.21	-0.16	-0.05	-0.15	0.11	-0.27	-0.13	0.58	-0.3	-0.22	-0.08
Net Debt	-0.67	-0.71	0.01		-0.5	-0.23	-0.04	-0.27	0.02	0.62	-0.79	0.84	0.86	-0.83	0.57	-0.59	-0.37	-0.15	0.27	-0.36	-0.25	-0.09
Retained Earnings	0.46	0.77	-0.21	-0.5		0.4	-0.75	0.2	0.13	-0.71	0.51	-0.14	-0.46	0.58	-0.4	0.59	0.2	0.19	-0.24	0.25	0.02	0.15
Accounts Payable	0.35	0.1	0.61	-0.23	0.4		0.03	0.37	0.11	-0.05	0.37	-0.09	-0.23	0.09	-0.52	0.7	-0.46	-0.34	0.58	-0.42	-0.51	-0.28
Long Term Debt	-0.18	-0.42	0.48	-0.04	-0.75	0.03		0.13	0.01	0.4	-0.16	-0.41	-0.1	-0.12	0.02	-0.08	-0.12	-0.09	0.22	-0.12	-0.06	-0.07
Net Receivables	0.31	0.26	0.33	-0.27	0.2	0.37	0.13		-0.22	-0.22	0.31	-0.27	-0.34	0.28	-0.14	0.16	0.13	0.36	0.17	0.08	0.5	0.39
Short Term Investments	-0.33	0.14	0.15	0.02	0.13	0.11	0.01	-0.22		-0.19	-0.3	-0.18	-0.26	0.19	-0.15	0.32	-0.01	0.11	-0.35	0.14	-0.42	0.04
Total Liab	-0.08	-0.99	0.18	0.62	-0.71	-0.05	0.4	-0.22	-0.19		-0.23	0.59	0.82	-0.93	0.55	-0.22	-0.73	-0.29	0.64	-0.8	-0.4	-0.14
Total Current Assets	0.97	0.37	-0.04	-0.79	0.51	0.37	-0.16	0.31	-0.3	-0.23		-0.37	-0.42	0.39	-0.36	0.66	-0.1	-0.02	0.19	-0.13	0.11	0.02
Short Term Debt	-0.23	-0.61	-0.21	0.84	-0.14	-0.09	-0.41	-0.27	-0.18	0.59	-0.37		0.92	-0.83	0.52	-0.33	-0.53	-0.23	0.4	-0.55	-0.29	-0.13
Property Plant Equipment	-0.27	-0.84	-0.16	0.86	-0.46	-0.23	-0.1	-0.34	-0.26	0.82	-0.42	0.92		-0.96	0.65	-0.44	-0.58	-0.23	0.45	-0.61	-0.29	-0.11
Net Tangible Assets	0.23	0.94	-0.05	-0.83	0.58	0.09	-0.12	0.28	0.19	-0.93	0.39	-0.83	-0.96		-0.6	0.33	0.7	0.3	-0.59	0.73	0.4	0.16
Long Term Investments	-0.17	-0.56	-0.15	0.57	-0.4	-0.52	0.02	-0.14	-0.15	0.55	-0.36	0.52	0.65	-0.6		-0.5	-0.19	0.48	0.11	-0.27	0.18	0.57
Short Long Term Debt	0.63	0.32	0.11	-0.59	0.59	0.7	-0.08	0.16	0.32	-0.22	0.66	-0.33	-0.44	0.33	-0.5		-0.31	-0.08	0.11	-0.21	-0.47	-0.06
Capital Surpluse	-0.21	0.68	-0.27	-0.37	0.2	-0.46	-0.12	0.13	-0.01	-0.73	-0.1	-0.53	-0.58	0.7	-0.19	-0.31		0.38	-0.8	0.9	0.69	0.24
Common Stock	0.06	0.3	-0.13	-0.15	0.19	-0.34	-0.09	0.36	0.11	-0.29	-0.02	-0.23	-0.23	0.3	0.48	-0.08	0.38		-0.43	0.39	0.56	0.98
Long Term Debt Total	0.29	-0.59	0.58	0.27	-0.24	0.58	0.22	0.17	-0.35	0.64	0.19	0.4	0.45	-0.59	0.11	0.11	-0.8	-0.43		-0.84	-0.39	-0.28
Net Invested Capital	-0.27	0.74	-0.3	-0.36	0.25	-0.42	-0.12	0.08	0.14	-0.8	-0.13	-0.55	-0.61	0.73	-0.27	-0.21	0.9	0.39	-0.84		0.6	0.22
Net Working Capital	0.08	0.4	-0.22	-0.25	0.02	-0.51	-0.06	0.5	-0.42	-0.4	0.11	-0.29	-0.29	0.4	0.18	-0.47	0.69	0.56	-0.39	0.6		0.51
Capital Stock	0.13	0.17	-0.08	-0.09	0.15	-0.28	-0.07	0.39	0.04	-0.14	0.02	-0.13	-0.11	0.16	0.57	-0.06	0.24	0.98	-0.28	0.22	0.51

Click cells to compare fundamentals

About VTv Therapeutics Financial Statements

VTv Therapeutics shareholders use historical fundamental indicators, such as Net Debt, to determine how well the company is positioned to perform in the future. Although VTv Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in VTv Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on VTv Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Net Debt	-8.9 M	-8.5 M
Net Debt To EBITDA	0.35	0.37

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for VTv Stock Analysis

When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

VTv Net Debt from 2010 to 2024

Latest VTv Therapeutics' Net Debt Growth Pattern

VTv Net Debt Regression Statistics

VTv Net Debt History

Other Fundumenentals of vTv Therapeutics

VTv Therapeutics Net Debt component correlations

About VTv Therapeutics Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for VTv Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY